Beck-PeccozP, ChatterjeeVK, ChinWW, DeGrootLJ, JamesonJL, NakamuraH, RefetoffS, UsalaSJ, WeintraubBD. 1994. Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, 10–11 July 1993, Cambridge, UK. Thyroid, 4:135–137.
2.
Beck-PeccozP, ChatterjeeVK, ChinWW, DeGrootLJ, JamesonJL, NakamuraH, RefetoffS, UsalaSJ, WeintraubBD. 1994. Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, 10–11 July 1993, Cambridge, UK. J Endocrinol Invest, 17:283–287.
3.
Beck-PeccozP, ChatterjeeVK, ChinWW, DeGrootLJ, JamesonJL, NakamuraH, RefetoffS, UsalaSJ, WeintraubBD. 1994. Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10–11, 1993, Cambridge, United Kingdom. J Clin Endocrinol Metab, 78:990–993.
4.
Beck-PeccozP, ChatterjeeVK, ChinWW, DeGrootLJ, JamesonJL, NakamuraH, RefetoffS, UsalaSJ, WeintraubBD. 1994. Nomenclature of thyroid hormone receptor-beta gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, 10–11th July 1993, Cambridge, UK. Eur J Endocrinol, 130:426–428.
5.
Beck-PeccozP, ChatterjeeVK, ChinWW, DeGrootLJ, JamesonJL, NakamuraH, RefetoffS, UsalaSJ, WeintraubBD. 1994. Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, 10–11 July 1993, Cambridge, UK. Clin Endocrinol (Oxf), 40:697–700.
6.
RefetoffS, DeWindLT, DeGrootLJ. 1967. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab, 27:279–294.
7.
FlamantF, BaxterJD, ForrestD, RefetoffS, SamuelsH, ScanlanTS, VennstromB, SamarutJ. 2006. International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev, 58:705–711.
8.
RefetoffS. 2008. Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat Clin Pract Endocrinol Metab, 4:1.
9.
RefetoffS, BassettJH, Beck-PeccozP, BernalJ, BrentG, ChatterjeeK, De GrootLJ, DumitrescuAM, JamesonJL, KoppPA, MurataY, PersaniL, SamarutJ, WeissRE, WilliamsGR, YenPM. 2014. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid, 24:407–409.
10.
RefetoffS, BassettJH, Beck-PeccozP, BernalJ, BrentG, ChatterjeeK, De GrootLJ, DumitrescuAM, JamesonJL, KoppPA, MurataY, PersaniL, SamarutJ, WeissRE, WilliamsGR, YenPM. 2014. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. J Clin Endocrinol Metab, 99:768–770.
11.
RefetoffS, BassettJH, Beck-PeccozP, BernalJ, BrentG, ChatterjeeK, De GrootLJ, DumitrescuAM, JamesonJL, KoppPA, MurataY, PersaniL, SamarutJ, WeissRE, WilliamsGR, YenPM. 2014. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Eur Thyroid J, 3:7–9.
12.
FlamantF, ChengSY, HollenbergAN, MoellerLC, SamarutJ, WondisfordFE, YenPM, RefetoffS. 2017. Thyroid hormone signaling pathways: time for a more precise nomenclature. Endocrinology, 158:2052–2057.
13.
HonesGS, RakovH, LoganJ, LiaoXH, WerbenkoE, PollardAS, PraestholmSM, SiersbaekMS, RijntjesE, GassenJ, LatteyerS, EngelsK, StrucksbergKH, KleinbongardP, ZwanzigerD, RozmanJ, Gailus-DurnerV, FuchsH, Hrabe de AngelisM, Klein-HitpassL, KohrleJ, ArmstrongDL, GrontvedL, BassettJHD, WilliamsGR, RefetoffS, FuhrerD, MoellerLC. 2017. Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo. Proc Natl Acad Sci U S A, 114:E11323–E11332.
